摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[3-(3-fluoroanilino)-6,7-dimethoxy-4H-indeno[1,2-c]pyrazol-1-yl]-4-oxobutanamide

中文名称
——
中文别名
——
英文名称
4-[3-(3-fluoroanilino)-6,7-dimethoxy-4H-indeno[1,2-c]pyrazol-1-yl]-4-oxobutanamide
英文别名
——
4-[3-(3-fluoroanilino)-6,7-dimethoxy-4H-indeno[1,2-c]pyrazol-1-yl]-4-oxobutanamide化学式
CAS
——
化学式
C22H21FN4O4
mdl
——
分子量
424.4
InChiKey
QRYPAPHDRFITIK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    31
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    109
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • [EN] N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS<br/>[FR] 3-AMINOPYRAZOLES TRICYCLIQUES N-SUBSTITUES COMME INHIBITEURS DES RECEPTEURS DU PDFG
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2003097609A1
    公开(公告)日:2003-11-27
    The invention is directed to N-substituted tricyclic 3-AMINOPYRAZOLE derivatives, which are useful as inhibitors of platelet-derived growth factor receptor (PDGF-R) kinase, and methods for the preparation of said derivatives. The present invention is further directed to pharmaceutical compositions comprising the compounds of the presentinvention and to methods for treating conditions such as tumors and other cell proliferative disorders.
    本发明涉及N-取代的三环3-氨基吡唑衍生物,其作为血小板源性生长因子受体(PDGF-R)激酶的抑制剂具有用途,以及制备该衍生物的方法。本发明还涉及包含本发明化合物的制药组合物,以及用于治疗肿瘤和其他细胞增殖性疾病的方法。
  • N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
    申请人:——
    公开号:US20040082639A1
    公开(公告)日:2004-04-29
    The invention is directed to N-substituted tricyclic 3-AMINOPYRAZOLE derivatives, which are useful as inhibitors of platelet-derived growth factor receptor (PDGF-R) kinase, and methods for the preparation of said derivatives. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions such as tumors and other cell proliferative disorders.
    该发明涉及N-取代的三环3-氨基吡唑衍生物,它们可用作血小板源性生长因子受体(PDGF-R)激酶的抑制剂,以及制备该衍生物的方法。本发明还涉及包含本发明化合物的药物组合物,以及治疗肿瘤和其他细胞增殖性疾病的方法。
  • N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
    申请人:Ho Yung Chih
    公开号:US20070142305A1
    公开(公告)日:2007-06-21
    The invention is directed to N-substituted tricyclic 3-AMINOPYRAZOLE derivatives, which are useful as inhibitors of platelet-derived growth factor receptor (PDGF-R) kinase, and methods for the preparation of said derivatives. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions such as tumors and other cell. proliferative disorders.
    本发明涉及N-取代的三环3-氨基吡唑衍生物,其可用作血小板源性生长因子受体(PDGF-R)激酶的抑制剂,以及制备该衍生物的方法。本发明进一步涉及包含本发明化合物的制药组合物,并用于治疗肿瘤和其他细胞增殖性疾病的方法。
  • N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS
    申请人:Janssen Pharmaceutica NV
    公开号:EP1506175B1
    公开(公告)日:2009-04-01
  • US7196110B2
    申请人:——
    公开号:US7196110B2
    公开(公告)日:2007-03-27
查看更多